Jennifer DeBerardinis Email

VP Procurement . Adverum Biotechnologies

Current Roles

Employees:
177
Revenue:
$34.3M
About
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. For more information, please visit www.adverum.com.
Adverum Biotechnologies Address
100 Cardinal Way
Redwood City, CA
United States
Adverum Biotechnologies Email

Past Companies

Adverum Biotechnologies, Inc.Vice President Procurement

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.